SUBSCRIBE
SUBSCRIBE
News   Business

Evotec AG Partners With Haplogen to Develop Drugs for Infectious Diseases

November 15, 2012 | 
1 min read

HAMBURG, Germany and VIENNA, Austria, Nov. 15, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) and Haplogen GmbH have signed a collaboration agreement to discover and develop small molecules against viral infectious diseases.

Alliances Europe
MORE ON THIS TOPIC
Pictured: Eli Lilly Campus in San Diego
Drug shortages
FDA Still Undecided About Shortage Status of Lilly’s Tirzepatide
November 22, 2024
 · 
2 min read
 · 
Tristan Manalac
A handshake of businessmen. Modern design with a positive context. Concept of help, support, and agreement between businessmen. Modern art collage, trendy magazine style.
Mergers & Acquisitions
Novartis CEO Promises More Deals of Up to $5B, With an Eye for Early Science
November 21, 2024
 · 
2 min read
 · 
Annalee Armstrong
Business
51%: The Untapped Market
November 21, 2024
 · 
1 min read
 · 
Lori Ellis
Novartis' office building in Marburg, Germany
Mergers & acquisitions
Novartis Buys Kate Therapeutics, Eyeing $55B CGT Market Opportunity by 2030
November 21, 2024
 · 
2 min read
 · 
Tristan Manalac